miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a Repair vs Suppression Frame

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-benzodiazepines`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-benzodiazepines

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-benzodiazepines/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-benzodiazepines/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-benzodiazepines/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-benzodiazepines/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
This is the largest single-authored interlocked logical structure published in the open that I am aware of: thousands of objects — a theory of everything, a theory of AI, and a replicated decision framework — where every piece fits every other piece, and every claim carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. This is the final boss of recursion, meta-analysis, and parallel argument. Come at a node.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Benzodiazepines

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. You are reading about Benzodiazepines — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

Why Benzodiazepines matters for you

  1. Drug: Benzodiazepines
  2. What it does: GABAergic suppression; does not rebuild neurochemistry.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 1
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Quantified confidence (this ledger): 0.2 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice (source s1)

Mouse study on LPS model showing mitochondrial and cognitive protection.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

What people say on Reddit

My Experience Treating my ME/CFS with mitochondrial peptides — Reddit, r/cfs (source s3)

User anecdote on SS-31 for energy and cognition in CFS.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Benzodiazepines · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 3 sources · swipe →chain 0ae53854e44c · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
preclinical
A 2019 mouse study showed SS-31 preserved mitochondrial membrane potential and ATP after LPS-induced stress and improved memory outcomes.
sources: s1
mechanistic
No human or animal studies directly examine SS-31 with benzodiazepines.
humanlow confidence
SS-31 received FDA approval for a rare pediatric mitochondrial disease in 2025 reports.
sources: s2
anecdotallow confidence
Reddit users report SS-31 for energy and cognition in ME/CFS but not for benzodiazepine issues.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:59
SS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a Repair vs Suppression Frame · 4 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Benzodiazepines
Slug: ss-31-benzodiazepines
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Benzodiazepines","condition_key":"benzodiazepines","primary_peptide":"ss-31","peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":["benzodiazepines"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"sectio
it output
{
  "slug": "ss-31-benzodiazepines",
  "title": "SS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a Repair vs Suppression Frame",
  "body": "## What's breaking down if you have Benzodiazepines\n\nLong-term benzodiazepine exposure involves chronic enhancement of GABA-A receptor activity. This leads to receptor downregulation and tolerance over time. Neuronal energy demands stay high while signaling adapts downward. Mitochondrial function in brain cells can decline because sustained GABAergic tone alters calcium handling and increases oxidative load in some models. If mitochondrial ATP production falls behind, repair of synapses and receptors slows. The result is a state where the original problem persists even if the drug is tapered, because breakdown outpaces cellular restoration.\n\nBenzodiazepines themselves do not rebuild receptor density or mitochondrial capacity. They suppress acute signals. That distinction matters when the goal is long-term neurochemical stability.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about Benzodiazepines — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial dysfunction in neurons forms part of the load after prolonged use, SS-31 (Elamipretide) is discussed because it targets repair at the inner mitochondrial membrane — not because it masks symptoms or directly modu
00a583541beef712
Machine verification: /api/articles/ss-31-benzodiazepines/contributions
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "A 2019 mouse study showed SS-31 preserved mitochondrial membrane potential and ATP after LPS-induced stress and improved memory outcomes."?
ask ss-31-benzodiazepines claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "No human or animal studies directly examine SS-31 with benzodiazepines."?
ask ss-31-benzodiazepines claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "SS-31 received FDA approval for a rare pediatric mitochondrial disease in 2025 reports."?
ask ss-31-benzodiazepines claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report SS-31 for energy and cognition in ME/CFS but not for benzodiazepine issues."?
ask ss-31-benzodiazepines claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on SS-31 for energy and cognition in CFS."
ask ss-31-benzodiazepines source s3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a Repair vs Suppression Frame — and what would you need me to tell you first?
ask ss-31-benzodiazepines condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a Repair vs Suppression Frame (studies vs anecdotes)?
ask ss-31-benzodiazepines good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →